Undervalued Stocks Based On Cash Flows

Results

789

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

789 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
CDG
€3.001.4%150.0%€28.0m€3.1745.337.4%1.2%Media
NORB B
SEK 11.350%-4.2%SEK 649.6mSEK 12.5023.545.8%0%Capital Goods
LIVE
UK£0.791.7%13.6%UK£309.7mUK£0.890.848.3%7.1%Real Estate
HIMS
US$30.825.1%-44.5%US$7.1bUS$29.233.068.5%n/aHealthcare
6526
JP¥2,028.50-15.4%-30.5%JP¥355.8bJP¥2,400.0046.333.2%2.5%Semiconductors
GREENPANEL
₹196.722.5%-28.1%₹24.1b₹245.561.672.9%0.3%Materials
COA
UK£0.81-3.8%10.1%UK£1.6bUK£1.1918.316.9%3.0%Consumer Durables
DBAN
€21.20-0.5%-11.7%€365.5m€34.537.354.5%4.7%Diversified Financials
CMTL
€1.86-1.6%2.8%€34.3m€3.078.918.2%n/aSoftware
OMDA
US$20.510.4%18.3%US$1.2bUS$25.004.3103.3%n/aHealthcare
1801
HK$86.00-3.7%-7.4%HK$149.7bHK$117.76158.532.4%n/aPharmaceuticals & Biotech
A299030
₩11,890.00-2.3%-45.5%₩95.1bn/a1.170.2%n/aCapital Goods
CNTL
CHF 6.16-6.9%268.4%CHF 502.7mCHF 8.3364.235.6%n/aFood, Beverage & Tobacco
DXRX
UK£1.4411.2%7.5%UK£121.5mUK£2.131252.687.0%n/aPharmaceuticals & Biotech
VSEC
US$194.39-0.5%32.9%US$5.4bUS$257.5679.526.6%0.2%Capital Goods
2310
ر.س13.24-2.6%-26.2%ر.س9.6bر.س16.721.9104.2%7.6%Materials
2259
HK$117.00-1.3%n/aHK$310.5bHK$200.1717.818.2%1.3%Materials
MODU
€1.05-1.4%-13.9%€44.6m€1.604.368.2%n/aHealthcare
002245
CN¥15.78-7.3%55.7%CN¥26.9bCN¥20.0035.232.6%0.4%Transportation
A089030
₩46,300.003.9%71.8%₩1.7t₩80,000.00361.7100.0%0.3%Semiconductors
6185
HK$23.14-1.1%-47.8%HK$9.8bHK$50.454.457.2%0%Pharmaceuticals & Biotech
KIST
UK£2.682.9%56.9%UK£222.3mUK£4.071.417.0%n/aEnergy
ALIG
SEK 127.602.2%-23.2%SEK 13.5bSEK 151.3324.622.2%2.6%Capital Goods
9926
HK$91.85-6.8%-39.6%HK$84.6bHK$169.7123.846.2%n/aPharmaceuticals & Biotech
Page 1 of 22